Sepsis is a life-threatening condition characterized by a dysregulated host response to infection, often leading to widespread inflammation, tissue damage, and organ failure. Despite advances in supportive care, sepsis remains a major clinical challenge, with the Centers for Disease Control and Prevention reporting that one in three patients who die in hospitals are affected by it. Survivors frequently experience long-term cognitive and physical impairments driven by immune dysregulation, including lymphocyte apoptosis and cellular reprogramming of innate immune cells, underscoring the urgent need for deeper mechanistic insights into the pathways that govern inflammation and immune dysfunction. Macrophages are central mediators of the innate immune response and play a critical role in orchestrating inflammation during bacterial infection. Upon sensing microbial components such as lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria, macrophages rapidly activate transcriptional programs driven by Toll-like receptor (TLR) signaling and the NF-κB signaling cascade. While this response is essential for pathogen clearance, its overactivation can lead to systemic inflammation and endotoxic shock. Long noncoding RNAs (lncRNAs) have emerged as key regulators of gene expression in immune cells, modulating transcription, chromatin architecture, and signaling pathways. Expressed in a highly cell-type- and stimulus-specific manner, lncRNAs are uniquely positioned to regulate the dynamic transcriptional programs that govern macrophage activation and inflammatory resolution. However, the functional roles of lncRNAs during sepsis and macrophage-mediated inflammation remain understudied.The long noncoding RNA GAPLINC (Gastric Adenocarcinoma Predictive Long Intergenic Noncoding RNA) was previously identified as a negative regulator of inflammation in macrophages. Upon LPS stimulation, Gaplinc expression is rapidly downregulated, and its loss results in elevated basal NF-κB nuclear localization, heightened inflammatory gene expression, and resistance to otherwise lethal endotoxic shock. However, the in vivo significance of Gaplinc expression level, its metabolic consequences, and the mechanism by which it acts remained unclear. The work presented in this dissertation characterizes the functional role of Gaplinc in macrophage inflammatory signaling, metabolic homeostasis, and susceptibility to endotoxic shock using complementary genetic mouse models. In Chapter 2, we generated a Gaplinc overexpressing transgenic mouse model and demonstrated that Gaplinc expression levels bidirectionally regulate macrophage inflammatory signaling and survival following LPS challenge. Overexpression suppressed basal NF-κB nuclear localization and downregulated inflammatory gene transcription in resting macrophages, resulting in increased susceptibility to endotoxic shock, with transgenic mice succumbing within 24 hours of LPS challenge. The correlation between Gaplinc expression level and severity of hypothermia following LPS challenge further supports an expression level-dependent role for this lncRNA in modulating the host response to endotoxin. In Chapter 3, we investigated whether Gaplinc deficiency is associated with distinct baseline metabolic profiles that could contribute to differential sepsis outcomes. Gene ontology analysis of Gaplinc-KO macrophages revealed transcriptional enrichment for phosphatidylcholine and glycerophospholipid metabolic pathways alongside downregulation of glycolysis, fatty acid elongation, and fatty acid biosynthesis. Untargeted metabolomics and targeted lipidomics of Gaplinc-KO plasma confirmed these transcriptional changes were reflected at the systemic level, with elevated lysophosphatidylcholines and reduced circulating free fatty acids across multiple chain lengths, metabolic profiles consistent with improved sepsis outcomes in the clinical literature. Gaplinc-KO macrophages also displayed reduced mitochondrial reactive oxygen species at baseline, and subcellular fractionation confirmed Gaplinc does not localize to mitochondria, indicating these effects are indirect.In Chapter 4, we examined whether Gaplinc functions in an expression level-dependent manner and whether its regulatory activity requires expression from its native locus. Heterozygous loss of a single Gaplinc allele was sufficient to rescue the full knockout transcriptional profile, consistent with haploinsufficiency, demonstrating that a threshold level of Gaplinc expression is required to maintain normal immune gene expression. Transgenic reintroduction of the spliced Gaplinc transcript on a distinct chromosomal locus into the knockout background largely restored wildtype gene expression, demonstrating that Gaplinc acts in trans and that the mature RNA product is sufficient for its regulatory function independently of its native locus. Together, these findings establish Gaplinc as an expression level-dependent, trans-acting regulator of macrophage inflammatory and metabolic homeostasis, with direct consequences for innate immune fitness and susceptibility to endotoxic shock. This work identifies Gaplinc expression level as a determinant of sepsis susceptibility and advances our understanding of how lncRNA abundance shapes innate immune outcomes, with broader implications for lncRNA-targeting therapeutic strategies in inflammatory disease.